Repare Therapeutics Inc share price logo

Repare Therapeutics Inc Share Price

NASDAQ: RPTX

Small Cap

$1.74

(+0.10%)

Live

as on

Repare Therapeutics Inc Stock Performance

as on September 17, 2025 at 10:40 pm IST

  • Day's Low

    Day's High

    $1.71
    $1.78
    downward going graph

    1.72%

    Downside

    2.30%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.89
    $4.07
    downward going graph

    48.85%

    Downside

    133.88%

    Upside

    downward going graph

Repare Therapeutics Inc share price movements today

Previous Close
$1.74
Open
$1.73
Volume
239.1K
Day's Low - High
$1.71 - $1.78
52 Week Low - High
$0.89 - $4.07

Repare Therapeutics Inc Historical Returns

1 Month Return
+ 10.83 %
3 Month Return
+ 22.54 %
1 Year Return
-47.11 %
3 Year Return
-86.1 %
5 Year Return
-94.87 %

Repare Therapeutics Inc Stock Fundamentals & Key Indicators

Check Repare Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$74.7M

EPS (TTM)

-1.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.86

Industry PE ratio

-3.9281873111782475

P/B Ratio

0

PEG Ratio

0

EBITDA

-110.5M

Revenue (TTM)

250.0K

Profit Margin

0.00%

Return On Equity TTM

112831300.00%

Repare Therapeutics Inc Stock Valuation

Track how Repare Therapeutics Inc P/E has moved over time to understand its valuation trends.

Repare Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Today (-1.86x)

September 17, 2025

Highest (-0.40x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.86x

Repare Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Repare Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$74.7M-94.87%-1.860.00%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Repare Therapeutics Inc Stock including INR - Dollar returns

The Repare Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Repare Therapeutics Inc investment value today

Current value as on today

₹57,486

Returns

₹42,514

(-42.51%)

Returns from Repare Therapeutics Inc Stock

₹47,112 (-47.11%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Repare Therapeutics Inc Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Repare Therapeutics Inc. Average target price of $5

Repare Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Repare Therapeutics Inc.

What analysts predicted

65.2%UPSIDE

Target Price

$5

Current Price

$1.74

Analyzed by

13 Analysts

Target

$5.00

Repare Therapeutics Inc target price $5, a slight upside of 65.2% compared to current price of $1.74. According to 13 analysts rating.

Repare Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Repare Therapeutics Inc Stock has decreased by -82% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-82% versus previous 30 day period

Repare Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
5
30
2
13
52
1
53
-53
-
0
Gross Profit
4
29
-8
12
51
0
40
0
-1
0
Operating Income
-34
-12
-38
-30
10
-37
-36
-30
-31
-17
EBITDA
-34
-11
-37
-30
11
-36
-34
-28
-31
-19
Interest Expense
3
-
-
3
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
1
1
Income Before Tax
-31
-8
-35
-27
13
-34
-33
-28
-29
-16
Income Tax Expense
3
3
-16
0
0
0
0
0
0
0
Net Income
-34
-11
-18
-28
13
-34
-34
-28
-30
-16
Net Profit Margin
-615.38%
-39.49%
-874.43%
-214.84%
25.12%
-3240.82%
-64.34%
53.61%
0.00%
-6697.60%

Repare Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
0
7
131
51
53
Gross Profit
0
0
0
-1
-80
15
37
40
Operating Income
-6
-12
-26
-54
-108
-19
-116
-93
EBITDA
-7
-13
-25
-53
-107
-17
-114
-90
Interest Expense
-
-
0
0
1
8
-
-
Depreciation
0
0
0
0
1
1
1
1
Income Before Tax
-7
-14
-27
-54
-108
-13
-103
-83
Income Tax Expense
0
0
0
-1
-1
15
-9
1
Net Income
-7
-14
-27
-53
-106
-29
-93
-84
Net Profit Margin
0.00%
0.00%
0.00%
-39568.15%
-1406.68%
-22.03%
-183.44%
-158.37%

Repare Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-11
-18
-28
13
-34
-34
-28
-30
-16
Operating Cash Flow
-34
-32
-28
11
-30
-30
-27
-29
-16
Investing Cash Flow
28
24
31
-20
7
31
31
28
0
Financing Cash Flow
0
0
0
0
-
0
0
0
-
Change in Cash
-5
-8
3
-8
-23
0
4
0
-16

Repare Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-14
-27
-53
-106
-29
-93
-84
Operating Cash Flow
-12
-18
-6
-85
0
-127
-76
Investing Cash Flow
0
-1
-9
-1
-175
78
49
Financing Cash Flow
103
103
247
95
0
0
0
Change in Cash
-13
84
231
8
-174
-48
-26

Global Institutional Holdings in Repare Therapeutics Inc

Funds
Holdings
Bvf Inc
24.09%
Blue Owl Capital Holdings LP
8.03%
Orbimed Advisors, LLC
7.75%
Versant Venture Management LLC
6.17%
Redmile Group, LLC
4.39%

Insights on Repare Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -53.47M → 250.0K (in $), with an average increase of 21490.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -30.04M → -16.74M (in $), with an average increase of 79.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 115.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 202.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, RPTX stock has moved down by -86.1%

About Repare Therapeutics Inc

repare therapeutics is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. its approach integrates insights from several fields of cell biology including dna repair and synthetic lethality. repare’s platform combines a proprietary, high throughput, crispr‐enabled gene editing target discovery method with high‐resolution protein crystallography, computational biology and clinical informatics. the company is backed by leading global healthcare investors including founding investor versant ventures and mpm capital. for additional information, please visit www.reparerx.com.
OrganisationRepare Therapeutics Inc
Headquarters7171 Frederick-Banting, Building 2, Montreal, QC, Canada, H4S 1Z9
IndustryHealth Technology
CEOMr. Steve Forte CPA
E-voting on sharesClick here to vote

Key Management of Repare Therapeutics Inc

Name

Title

Dr. Joseph P. O'Connell M.D.

Executive Vice President of Clinical Development and Medical Affairs

Dr. Michael Zinda Ph.D.

Executive VP & Chief Scientific Officer

Mr. Steve Forte CPA

President, CFO, CEO & Director

Dr. Daniel Durocher Ph.D.

Co-Founder

Dr. Frank Sicheri Ph.D.

Co-Founder

Dr. Agnel Sfeir Ph.D.

Co-Founder

Ms. Sandra Alves

Senior VP & Chief Accounting Officer

Mr. Daniel Belanger

Executive Vice President of Human Resources

FAQs

What is Repare Therapeutics Inc share price today?

Repare Therapeutics Inc share price today is $1.74 as on . Repare Therapeutics Inc share today touched a day high of $1.78 and a low of $1.71.

What is the 52 week high and 52 week low for Repare Therapeutics Inc share?

Repare Therapeutics Inc share touched a 52 week high of $4.07 on and a 52 week low of $0.89 on . Repare Therapeutics Inc stock price today i.e. is trending at $1.74,which is 57.24% down from its 52 week high and 95.51% up from its 52 week low.

What is Repare Therapeutics Inc's market capitalisation today?

Repare Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Repare Therapeutics Inc Stock (RPTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Repare Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Repare Therapeutics Inc Shares that will get you 0.8621 shares as per Repare Therapeutics Inc share price of $1.74 per share as on September 17, 2025 at 10:40 pm IST.

What is the minimum amount required to buy Repare Therapeutics Inc Stock (RPTX) from India?

Indian investors can start investing in Repare Therapeutics Inc (RPTX) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Repare Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Repare Therapeutics Inc share’s latest price of $1.74 as on September 17, 2025 at 10:40 pm IST, you will get 5.7471 shares of Repare Therapeutics Inc. Learn more about fractional shares .

What are the returns that Repare Therapeutics Inc has given to Indian investors in the last 5 years?

Repare Therapeutics Inc stock has given -94.87% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?